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Abstract 
Purpose: To investigate the expression of complement factors in pterygium tissues compared to normal 
conjunctival samples, using next-generation RNA sequencing 
Methods: Twenty pterygium and 20 healthy conjunctival samples were obtained from 19 patients who 
consented to pterygium excision and conjunctival autograft surgery. Tissues (pterygium and normal 
conjunctiva) were analyzed using next-generation RNA sequencing. Significant gene lists were obtained 
using DAVID, GSEA, and KEGG for enriched pathway analyses of differentially expressed genes. Real-
time polymerase chain reaction was performed to validate differential expressions of complement 
factors.  
Results: There was 3.15 ± 2.6, 3.21 ± 4.6, 3.03 ± 1.83, 4.28 ± 6.12, and 4.96 ± 1.89-fold increase in the 
expression of CFH, C2, C1QB, C1QC, and MASP1, respectively, in pterygium samples compared to 
normal conjunctival samples. Pterygium size correlated well with the expression of CFH, C1QB, C1QC 
and MASP1. 
Conclusion: Alternative and lectin complement systems are activated in pterygia samples compared to 
normal conjunctival samples.  
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Pterygium is an overgrowth of fibrovascular 
tissue, with a winglike appearance, from the 
conjunctiva over the cornea [1,2]. Although 
several theories on its pathogenesis have been 
postulated, including immunological 
mechanisms, infection, and ultraviolet exposure 
[3-5], the definitive cause of pterygium is still not 
known. Some studies reported that 
immunological mechanisms such as type 1, 3, 
and 4 hypersensitivities might contribute to its 
pathogenesis, and large numbers of infiltrating 
lymphocytes, predominantly T-cells (CD3+), 
have been found in the substantia propria of 
pterygium specimens [6,7]. 
  
The complement system is a part of the immune 
system that boosts the ability of antibodies 
and phagocytic cells to clear bacteria and 
damaged cells from the host. Complement 
activation products mediate immune reactions 
and the expression of many inflammatory 
cytokines [8-10], and the complement pathway 
has been related with the pathogenesis of many 
diseases. Variants in several genes, such as 
complement 2 (C2), complement 3 (C3), 
complement factor H (CFH), and complement 
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factor B (CFB),  encoding complement pathway 
proteins, have been associated with age-related 
macular degeneration [11]. 
 
The classical pathway is triggered by activation 
of the C1-complex. The C1-complex is 
composed of C1q, C1r and C1s, or C1qr2s2. 
This occurs when C1q binds to IgM or IgG 
complexed with antigens. The binding of C1q to 
a ligand results in a conformational change which 
leads to the sequential activation of C1r and C1s 
[12]. The alternative pathway dose not require a 
specific protein for the initiation stage. 
Spontaneous hydrolysis of C3 leads to 
constitutively low-grade complement activation 
[13]. The lectin pathway is initiated by the 
recognition of carbohydrate molecules (MBL, N-
acetyl-glucosamine, mannose, fucose or 
glucose, and ficolins) on the surface of viruses, 
bacteria, and other pathogenic organisms [14]. 
MBL-associated serine proteases 1 and 2 are 
complexed with MBL and are stimulated upon 
MBL binding to sugar moieties, subsequently 
cleaving C4 and C2 to form the classical pathway 
of C3 convertase, C4b, and C2a [15]. 
 
Next-generation sequencing is a technique that 
parallelizes the sequencing process, allowing 
concurrent high-throughput genome sequencing. 
To characterize the immunopathology of 
pterygium, we used this next-generation RNA 
sequencing methodology to identify genes 
associated with pterygia that were not expressed 




Patients and samples 
 
The present study was reviewed and approved 
by the Institutional Review Board of Dankook 
University Hospital, Yongin, The Republic of 
Korea (code: 2016-04-016), and it adhered to the 
tenets of the Declaration of Helsinki [16]. Twenty 
pterygium and 20 normal conjunctival samples 
were obtained from 19 patients who underwent 
pterygium excision and conjunctival autograft 
surgery after obtaining their written informed 
consent. 
  
RNA isolation and sequencing 
 
Total RNA was obtained from pterygium and 
normal conjunctival samples using an RNeasy 
Micro kit (Qiagen, San Diego, CA, USA) 
according to the manufacturer's instructions. 
Total RNA quality and quantity were confirmed 
using a NanoDrop 2000 spectrometer (Thermo 
Scientific, Waltham, MA, USA) and Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA, 
USA). To build Illumina-compatible libraries, we 
used a TruSeq RNA library preparation kit 
(Illumina, San Diego, CA, USA) according to the 
manufacturer's instructions. TruSeq RNA 
libraries constructed by polymerase chain 
reaction (PCR) amplification were quantified 
using quantitative PCR (qPCR) according to the 
qPCR Quantification Protocol Guide, and their 
quality was assessed using a Bioanalyzer 2100 
(Agilent Technologies). The amplified library was 
sequenced using a HiSeq™ 2000 system 
(Illumina). 
 
Raw read filtering and alignment with a 
human reference genome 
 
Raw read filtering using Trim Galore (Babraham 
Bioinformatics, http://www.bioinformatics.babra 
ham. ac.uk/projects/trim_galore) used the default 
value to remove the reads with sequence 
adaptors and the low-quality reads. All 
subsequent analyses were based on the clean 
reads. The reference sequences were 
downloaded from the University of California at 
Santa Cruz genome browser (version hg19, 
https://genome.ucsc.edu/cgi-bin/hgGateway?db= 
hg 19). Trimming reads were respectively aligned 
to the reference genome using RNA-STAR 
(https://github.com/alexdobin/ STAR). 
 
Analyses of differential expression and 
functional annotations 
 
Reads uniquely mapped to a gene were 
calculated using the Cufflink package according 
to the default values. The gene expression level 
was expressed as the number of uniquely 
mapped fragments per kilobase of exon region 
per million mappable reads. Genes differentially 
expressed between paired pterygium and normal 
conjunctival samples were determined based on 
values of p ≤ 0.05 and fold change ≥ 2. 
Significant gene lists were generated using 
DAVID (Database for Annotation, Visualization, 
and Integrated Discovery, https://david.ncifcrf. 
gov/), GSEA (Gene Set Enrichment Analysis 
http://software.broadinstitute.org/gsea/index.jsp), 
and KEGG (Kyoto Encyclopedia of Genes and 
Genomes, http://www.genome.jp/kegg/) to 
produce functional annotation of differentially 
expressed genes. DAVID is a bioinformatics tool 
that systematically extracts biological meaning 
from large gene lists. GSEA generated a ranking 
based on the correlation of genes differentially 
expressed between pterygium and normal 
conjunctival samples. KEGG is a computational 
description of biological systems, consisting of 
the molecular structure of genes and proteins, 
integrated with information on molecular pattern 
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charts of interaction, reaction, and association 
networks. 
 
cDNA synthesis and real-time analysis 
 
The cDNA synthesis was performed using an 
iScriptTM cDNA synthesis kit (Bio-Rad, Hercules, 
CA, USA) according to the manufacturer’s 
instructions. Real-time PCR (RT-PCR) was 
performed using the StepOne Plus real-time 
PCR system (Applied Biosystems, Foster City, 
CA, USA) with SYBR® Green PCR Master Mix 
(Applied Biosystems) according to the standard 
manufacturer’s instructions. Primers were 
purchased from Bioneer (Daejeon, The Republic 
of Korea). Primer sequences are listed in Table 
1. 
 
Evaluation of the pterygium area of the 
cornea 
 
Photographic images of Anterior segment were 
imported into Adobe Photoshop CS5 (Adobe 
Systems, San Jose, CA, USA). Borders of the 
pterygium and cornea were marked, and the 
“pixel counter” tool was used to quantify and 
compare pixel counts in the digital image. The 
size of pterygium was calculated based on the 





Statistical analysis was performed using SPSS 
statistical software for Windows, version 23.0 
(SPSS, Chicago, IL, USA). A paired t-test was 
used to compare the expression of complement 
factors between pterygium and normal 
conjunctival samples. Pearson’s correlation 
analysis was used to determine possible 
correlations between pterygium size and the 
expression of complement factors. A value of p < 





The mean age ± SD of 19 patients (10 females, 9 
males) was 59.9 ± 7.4 years. Seventeen of the 
20 collected pterygium samples were primary 
pterygium samples, and the remaining three 




RNA sequencing results 
 
We studied the differentially expressed genes 
using RNA sequencing in eight pterygium 
samples and their matched healthy conjunctival 
samples. As a result, we generated an average 
of 55,550,533 reads (range: 43,439,664–
80,389,513 reads). Also, we used the Spliced 
Transcripts Alignment to a Reference (STAR, 
http://pipe-star.readthedocs.io/en/latest/explain_ 
star.html) to map the reads to a human genome 
(UCSC hg19, http://hgdownload.cse.ucsc.edu/ 
downloads.html), thus obtaining an average 
value of 93 %. 
 
By comparing the transcriptome sequences of 
the pterygium samples and their matched 
conjunctival samples, several differentially 
expressed transcripts were identified. 
Furthermore, 917 genes were differentially 
expressed with a fold change ≥ 2 and p < 0.05, 
and among them, there were 641 upregulated 
genes and 276 downregulated genes. We 
performed future analyses of the differentially 
expressed gene functions using DAVID, the 
Gene Set Enrichment Assay, and the KEGG 
pathway. 
 
Table 1: Primers for complement factor amplification 
 
Gene Direction Sequence 5' > 3' Tm (°C) Product size (base pairs) 
CFH 
F TTGTCTCCTGACCTCCCAA 56.4 
122 
R TCCACCACTTCACTGTGTC 56 
C1QB 
F GACCCCAGGGATAAAAGGAGA 57.5 
110 
R GGCCGACTTTTCCTGGATT 56.8 
C1QC 
F ATGGGTACGACGGACTGC 58.2 
125 
R GGGGCCATTTTTCCCAGG 57.3 
MASP1 
F GGGACGTGGAGTAACAAGAT 56 
118 
R CAGACTTGTATGTGGTGAGGT 56.3 
C2 
F TCGAATCTTGTGCTCACGG 56.9 
113 
R ACGTCCTCAGGGAAGTCATAA 57.2 
F = forward; R = reverse; CFH = complement factor H; C1QB, C1QC = C1 complexes; MASP1 = 
mannose-binding lectin (MBL)-associated serine protease 1. Tm = melting temperature 
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As a result, we found that CFH, C1QA, C1QB, 
and C1QC were differentially expressed between 
pterygium and matched conjunctival samples 
(Table 2) and they were clustered in the 
complement system. 
 
Table 2: Fold-change from RNA sequence analyses 
 
Gene Log2FC Fold-change P-value 
CFH 1.12 2.17 0.00  
C2 0.53 1.44 0.21  
C3 0.06 1.04 0.87  
C1QA 1.17 2.25 0.03  
C1QB 1.41 2.66 0.01  
C1QC 1.23 2.34 0.01  
MASP1 0.34 1.27 0.53 
FC = fold changes; CFH = complement factor H; 
C1QA, C1QB, C1QC = C1 complexes; MASP1 = 
mannose-binding lectin (MBL)-associated serine 
protease 1 
 
Table 3: Correlation between pterygium size and the 
expression of complement factors 
 
Variable CFH C2 C1QB C1QC MASP1 
Size of 




0.005 0.074 0.029 0.013 0.002 
The size of pterygium = percentage of pterygium area 
on the cornea; CFH = complement factor H; C1QB, 
C1QC = C1 complexes; MASP1 = mannose-binding 
lectin (MBL)-associated serine protease 1; Sig = 
significance. 
 
Validation of complement factor 
overexpression using RT-PCR  
 
Quantitative real time PCR (qRT-PCR) was 
performed for confirming the relationship of the 
complement system genes with pterygium.  
 
As a result, complement factor genes (CFH, C2, 
C1QB, C1QC, and MASP1) were upregulated 
more than 2-fold. Notably, CFH and C1QB genes 
increased more than three-fold change and 
showed significant expression changes (p 
<0.001) compared to those in normal 
conjunctival tissue (Figure 1). 
 
Relationship between gene expression and 
pterygium size  
 
The range of the pterygium in the cornea was the 
measurement obtained for confirming the 
correlation between complement-related genes 
and pterygium size in 19 patients. As a result, the 
size of the pterygium increased when 
complement-related genes overexpressed 
compared to those in matched normal 
conjunctival tissues (Table 3, Figure 2A). 
Conversely, when complement-related genes 
were relatively less expressed, the size of the 
pterygium was small (Table 3, Figure 2B). 
 
 
Figure 1: The relative gene expression of 
complement factors compared with the 
expression of controls (paired t-test). CFH: 
complement factor H; C1QB, C1QC: C1 
complexes; MASP1: mannose-binding lectin 
(MBL)-associated serine protease 1. *p < 0.05, 




Next-generation RNA sequencing has increased 
ourability to identify specific proteins involved in 
many diseases [17,18]. In the present study, this 
technique was used to identify putative 
differences in pterygia samples when compared 
with normal conjunctival samples. We observed 
that several genes were found to be 
overexpressed, or underexpressed in pterygia 
tissues when compared with matched normal 
conjunctival tissues.  To the best of our 
knowledge, this is the first study to compare 
samples of pterygia and healthy conjunctivas 
using next-generation RNA sequencing. The 
results provide many new opportunities to study 
the causes and diagnoses of pterygium. 
 
RT-PCR assays were performed to validate the 
overexpression of complement factors CFH, C2, 
C1QB, C1QC, and MASP1. We tried to 
determine the expression pattern of all 
complement pathways, including the classic 
pathway (C2, C1QB, and C1QC), the lectin 
pathway (C2 and MASP1), and the alternative 
pathway (CFH). The results showed that all of 
these complement factors were significantly 
increased in pterygia samples compared to 
normal conjunctival samples. 
 
The complement system, a protein cascade 
involved in immune response, consists of several 
soluble and cell membrane-associated proteins 
[19]. This cascade is a part of the immune 
system that enhances the ability of antibodies 
and phagocytes to clear bacteria and damaged 
cells from an organism. The biochemical 
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Figure 2: Representative images of large and small pterygia. A: A 54-year-old male with a large primary 
pterygium and high overexpression of complement factors. B: A 66-year-old male with a small primary pterygium 
and low overexpression of complement factors. Size (%): calculated percentage of the pterygium area on the 
cornea. CFH: complement factor H; C1QB, C1QC: C1-complexes; MASP1: mannose-binding lectin (MBL)-
associated serine protease 1. 
 
pathways that activate the complement system 
consist of the classical complement pathway, the 
alternative complement pathway, and the lectin 
pathway [20]. The classical pathway is stimulated 
upon binding of C1q to antibody-opsonized target 
cells. The lectin pathway is activated by 
mannose-binding lectin (MBL). The alternative 
pathway is induced by infectious agents including 
bacteria, viruses, and fungi. All pathways 
converge at the level of C3 to initiate the terminal 
pathway, which leads to the formation of C5b-9. 
In addition, anaphylatoxins, C3a and C5a, recruit 
immune cells to the site of inflammation [21]. 
 
To avoid damage to surrounding tissues, both 
soluble and membrane-bound regulators tightly 
regulate the complement system. The C1 
inhibitor binds to C1r, C1s, and MASP-2 to 
prevent further cleavage of C4. C4b-binding 
protein inactivates the classical C3 convertase 
pathway and factors H, and I inhibit the 
alternative C3 convertase pathway by cleaving 
C3b in the enzyme complex [21]. CFH is a key 
regulator of the complement system in innate 
immunity that maintains the optimum C3 level in 
circulation [22]. Genetic alterations, including 
absolute factor H deficiency, have been 
associated with membranoproliferative 
glomerulonephritis and hemolytic uremic 
syndrome [23]. In our study, CFH was 
overexpressed in pterygia tissue compared to 
normal conjunctival tissue, but C3 expression 
was not increased. This might be the result of 
regulation by CFH. 
 
We found that complement factors are 
overexpressed in pterygia samples compared to 
normal conjunctival samples. However, the 
magnitude of the changes differed among 
patients. We tried to identify the factors 
associated with these variations. Using 
Pearson’s correlation analyses, the size of the 
pterygium was correlated with the amount of 
complement factor expression. The occurrence 
and growth of pterygium are associated with 
immunological reaction and inflammation [6]. 
Therefore, large size of the pterygium might 
induce more severe activation of the complement 
pathway. This implies that the amount of 
complement factor reflected the severity of the 
pterygium and that, in clinical practice, detection 
of gene expression changes could be used to 
predict post-surgical lesions in the pterygium. 
However, the exact role of complement factors in 
the pathogenesis of pterygium is still not 
completely understood. The pathogenesis of 
pterygium resulting from ultraviolet (UV) light 
damage, oxidative stress, and microbial infection 
might activate the complement system such as 
the classic pathway (C2, C1QB, and C1QC) and 
the lectin pathway (C2 and MASP1). UV 
radiation in sunlight are the prime cause of skin 
cancer in humans, with both UVA and UVB 
wavelengths being important in photo-
carcinogenesis. UV radiation has various 
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biological effects on carcinogenesis [24]. Some 
of these effects, as well as other forms of stress, 
may activate the complement system [24] and 
cause chronic inflammation of the conjunctiva 
and limbus, resulting in initiation and progression 
of pterygium. Recent evidence suggests that 
potentially oncogenic viruses such as human 
papillomavirus and Epstein-Barr virus may be 
involved in the pathogenesis of pterygia [25]. 
Infection might be related to activation of the 
alternative pathway (CFH) and the lectin 
pathways (C2 and MASP1) in the pathogenesis 
of pterygium. The alternative and lectin pathway 
are induced by exposure to infectious agents 




The alternative and lectin complement systems 
are activated in pterygia samples compared to 
normal conjunctival samples. CFH is also 
overexpressed in pterygium samples. Pterygium 
size correlates with the amount of complement 
factor expression. Complement factors could be 
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